Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William F Forrest

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Molecular Cancer Therapeutics|March 10, 2012
ERK inhibition overcomes acquired resistance to MEK inhibitorsGeorgia Hatzivassiliou, Bonnie Liu, Carol O'Brien, et al.
NPJ Breast Cancer|July 20, 2017
The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant populationTimothy R Wilson, Jianjun Yu, Xuyang Lu, et al.
Scientific Reports|March 17, 2021
Ocular phenotypes in a mouse model of impaired glucocerebrosidase activityMartin Weber, Sang-Won Min, Tom Truong, et al.
Cell Chemical Biology|May 16, 2025
Engineering ERα degraders with pleiotropic ubiquitin ligase ligands maximizes therapeutic efficacy by co-opting distinct effector ligasesAnna Shemorry, Willem den Besten, Melinda M Mulvihill, et al.
Nature Biotechnology|May 25, 2010
Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse modelsMallika Singh, Anthony Lima, Rafael Molina, et al.
The Journal of Pathology|May 22, 2012
Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour modelsMallika Singh, Suzana S Couto, William F Forrest, et al.
The Lancet. Respiratory Medicine|June 13, 2018
Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing studyAmy Dressen, Alexander R Abbas, Christopher Cabanski, et al.
Analytical Chemistry|March 6, 2023
Quantifying KRAS G12C Covalent Drug Inhibitor Activity in Mouse Tumors Using Mass SpectrometryJohn C Tran, Thomas Hunsaker, Christina Bell, et al.
Scientific Reports|April 3, 2022
A whole genome sequencing study of moderate to severe asthma identifies a lung function locus associated with asthma riskDiana Chang, Julie Hunkapiller, Tushar Bhangale, et al.
Cancer Cell|April 14, 2010
A hierarchy of self-renewing tumor-initiating cell types in glioblastomaRuihuan Chen, Merry C Nishimura, Stephanie M Bumbaca, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|March 10, 2012
ERK inhibition overcomes acquired resistance to MEK inhibitorsGeorgia Hatzivassiliou, Bonnie Liu, Carol O'Brien, et al.
NPJ Breast Cancer|July 20, 2017
The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant populationTimothy R Wilson, Jianjun Yu, Xuyang Lu, et al.
Scientific Reports|March 17, 2021
Ocular phenotypes in a mouse model of impaired glucocerebrosidase activityMartin Weber, Sang-Won Min, Tom Truong, et al.
Cell Chemical Biology|May 16, 2025
Engineering ERα degraders with pleiotropic ubiquitin ligase ligands maximizes therapeutic efficacy by co-opting distinct effector ligasesAnna Shemorry, Willem den Besten, Melinda M Mulvihill, et al.
Nature Biotechnology|May 25, 2010
Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse modelsMallika Singh, Anthony Lima, Rafael Molina, et al.
The Journal of Pathology|May 22, 2012
Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour modelsMallika Singh, Suzana S Couto, William F Forrest, et al.
The Lancet. Respiratory Medicine|June 13, 2018
Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing studyAmy Dressen, Alexander R Abbas, Christopher Cabanski, et al.
Analytical Chemistry|March 6, 2023
Quantifying KRAS G12C Covalent Drug Inhibitor Activity in Mouse Tumors Using Mass SpectrometryJohn C Tran, Thomas Hunsaker, Christina Bell, et al.
Scientific Reports|April 3, 2022
A whole genome sequencing study of moderate to severe asthma identifies a lung function locus associated with asthma riskDiana Chang, Julie Hunkapiller, Tushar Bhangale, et al.
Cancer Cell|April 14, 2010
A hierarchy of self-renewing tumor-initiating cell types in glioblastomaRuihuan Chen, Merry C Nishimura, Stephanie M Bumbaca, et al.
Pageof 5